hVIVO plc (LON:HVO – Get Free Report) rose 10% during mid-day trading on Tuesday . The stock traded as high as GBX 22 ($0.27) and last traded at GBX 21.25 ($0.26). Approximately 7,804,669 shares were traded during trading, an increase of 164% from the average daily volume of 2,961,263 shares. The stock had previously closed at GBX 19.33 ($0.24).
hVIVO Trading Up 0.4 %
The company has a debt-to-equity ratio of 33.86, a current ratio of 1.61 and a quick ratio of 1.16. The stock’s 50 day moving average is GBX 20.01 and its 200-day moving average is GBX 25.58. The company has a market capitalization of £129.75 million, a P/E ratio of 635.67 and a beta of 0.97.
hVIVO Company Profile
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Featured Articles
- Five stocks we like better than hVIVO
- Upcoming IPO Stock Lockup Period, Explained
- Coinbase Gains Momentum on App Store—What It Means for the Stock
- How to Use the MarketBeat Stock Screener
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- What is the NASDAQ Stock Exchange?
- 3 Steel Stocks Soaring After Tariff Announcements
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
